Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
ATYR (aTYR PHARMA INC) has 0 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
91 institutional managers report a position in aTYR PHARMA INC worth $23.7M between them, filed on form 13F for the quarter ending 2026-06-30. 12 of them hold 80% of it, the largest being Federated Investors Inc at 21.47%.
66 more managers in the register
12 managers hold 80% of the $23.7M institutional base. The other 79 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
aTYR PHARMA INC
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 0.39 · gapped above the open, then crossed back over prior close. High/low 0.40 at 4:30 am ET, 0.38 at 10:30 am ET.
via Federated Investors Inc · 21.47% of ATYR, 14.50% of RZLT
via Federated Investors Inc, Marshall Wace LLP · 21.47% of ATYR, 13.21% of ARCT
via Federated Investors Inc, Marshall Wace LLP · 21.47% of ATYR, 11.95% of LFMD
via Federated Investors Inc · 21.47% of ATYR, 11.04% of NERV
via Federated Investors Inc, Qube Research & Technologies Ltd · 21.47% of ATYR, 10.32% of INNV
via Federated Investors Inc · 21.47% of ATYR, 10.31% of FBRX
Managers holding a meaningful stake in ATYR also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.